Literature DB >> 29482773

The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers.

Sevtap Savas1, Georgia Skardasi2.   

Abstract

SWI/SNF is a multiprotein complex essential for regulation of eukaryotic gene expression. In this article, we review the function and characteristics of this complex and its subunits in cancer-related phenotypes. We also present and discuss the publically available survival analysis data for TCGA patient cohorts, revealing novel relationships between the expression levels of the SWI/SNF subunit genes and patient survival times in several cancers. Overall, multiple lines of research point to a wide-spread role for the SWI/SNF complex genes in human cancer susceptibility and patient survival times. Examples include the mutations in ARID1A with cancer-driving effects, associations of tumor SWI/SNF gene expression levels and patient survival times, and two BRM promoter region polymorphisms linked to risk or patient outcomes in multiple human cancers. These findings should motivate comprehensive studies in order to fully dissect these relationships and verify the potential clinical utility of the SWI/SNF genes in controlling cancer.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BRG1; BRM; Cancer; Cancer susceptibility; Chromatin remodeling; Indels; SWI/SNF complex; Survival outcomes

Mesh:

Substances:

Year:  2018        PMID: 29482773     DOI: 10.1016/j.critrevonc.2018.01.009

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  30 in total

1.  ARID1A knockdown triggers epithelial-mesenchymal transition and carcinogenesis features of renal cells: role in renal cell carcinoma.

Authors:  Keerakarn Somsuan; Paleerath Peerapen; Wanida Boonmark; Sirikanya Plumworasawat; Ratirath Samol; Natthiya Sakulsak; Visith Thongboonkerd
Journal:  FASEB J       Date:  2019-08-21       Impact factor: 5.191

2.  BRM Targeting Compounds for the Potential Treatment of Cancer.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2020-01-24       Impact factor: 4.345

3.  Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities.

Authors:  Krystal A Orlando; Vinh Nguyen; Jesse R Raab; Tara Walhart; Bernard E Weissman
Journal:  Expert Rev Anticancer Ther       Date:  2019-05-13       Impact factor: 4.512

4.  PLK1 inhibition selectively induces apoptosis in ARID1A deficient cells through uncoupling of oxygen consumption from ATP production.

Authors:  Upadhyayula S Srinivas; Norbert S C Tay; Patrick Jaynes; Akshaya Anbuselvan; Gokula K Ramachandran; Joanna D Wardyn; Michal M Hoppe; Phuong Mai Hoang; Yanfen Peng; Sherlly Lim; May Yin Lee; Praveen C Peethala; Omer An; Akshay Shendre; Bryce W Q Tan; Sherlyn Jemimah; Manikandan Lakshmanan; Longyu Hu; Rekha Jakhar; Karishma Sachaphibulkij; Lina H K Lim; Shazib Pervaiz; Karen Crasta; Henry Yang; Patrick Tan; Chao Liang; Lena Ho; Vartika Khanchandani; Dennis Kappei; Wei Peng Yong; David S P Tan; Matteo Bordi; Silvia Campello; Wai Leong Tam; Christian Frezza; Anand D Jeyasekharan
Journal:  Oncogene       Date:  2022-03-02       Impact factor: 9.867

5.  A case report of malignant neuroectodermal tumor of the gastrointestinal tract without common gene fusion in a soft tissue tumor.

Authors:  Zi-Lin Liu; Bin Zhou; Yi-Jun Zhao; Miao-Qing Yu; Jie Liang; Yong Li
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 6.  EZH2-Targeted Therapies in Cancer: Hype or a Reality.

Authors:  Marie-Lisa Eich; James E Ferguson; Sooryanarayana Varambally; Mohammad Athar
Journal:  Cancer Res       Date:  2020-09-25       Impact factor: 12.701

7.  Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer.

Authors:  Yajun Yu; Dangxiao Cheng; Patrick Parfrey; Geoffrey Liu; Sevtap Savas
Journal:  PLoS One       Date:  2018-06-12       Impact factor: 3.240

8.  INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication.

Authors:  Updesh Dixit; Savita Bhutoria; Xuhong Wu; Liming Qiu; Menachem Spira; Sheeba Mathew; Richard Harris; Lucas J Adams; Sean Cahill; Rajiv Pathak; P Rajesh Kumar; Minh Nguyen; Seetharama A Acharya; Michael Brenowitz; Steven C Almo; Xiaoqin Zou; Alasdair C Steven; David Cowburn; Mark Girvin; Ganjam V Kalpana
Journal:  Nat Commun       Date:  2021-05-12       Impact factor: 14.919

Review 9.  The SWI/SNF complex in cancer - biology, biomarkers and therapy.

Authors:  Priya Mittal; Charles W M Roberts
Journal:  Nat Rev Clin Oncol       Date:  2020-04-17       Impact factor: 66.675

10.  SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer.

Authors:  Zhao-Ming Xiao; Dao-Jun Lv; Yu-Zhong Yu; Chong Wang; Tao Xie; Tao Wang; Xian-Lu Song; Shan-Chao Zhao
Journal:  Front Cell Dev Biol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.